Babiker, H. M., Brana, I., Mahadevan, D., Owonikoko, T. K., Calvo, E., Rischin, D., Moreno, V., Papadopoulos, K. P., Crittenden, M., Formenti, S., Giralt, J., Garrido, P., Hervás Morón, A., Mohan, K. K., Fury, M. G., Lowy, I., Stankevich, E., Feng, M., Li, J., & Mathias, M. (n.d.). 74PPhase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095517037.0x00003c